Chapter 5
References
1.
Ockenga
J, Valentini L. Review article: anorexia and cachexia in
gastrointestinal cancer. Aliment Pharmacol Ther. 2005 Oct 1;22(7):583-94.
Dell DD. Cachexia in patients with advanced
cancer.
Clin J Oncol Nurs. 2002 Jul-Aug;6(4):235-8.
Mahmoud FA, Rivera NI.
The role of C-reactive protein as a prognostic indicator in advanced
cancer.
Curr
Oncol Rep. 2002 May;4(3):250-5.
Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K,
Kustrzeba-Wojcicka I, Terlecki G, Gamian A.
Acute-phase response proteins are related to cachexia and accelerated
angiogenesis in gastroesophageal cancers. Clin Chem Lab Med. 2008;46(3):359-64.
Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L,
Catalano MG, Aragno M, Boccuzzi G.
Pro-inflammatory cytokines and oxidative stress/antioxidant parameters
characterize the bio-humoral profile of early cachexia in lung cancer patients.
Oncol Rep. 2007 Dec;18(6):1521-7.
2.
McMillan
DC. An inflammation-based prognostic score and its role in the
nutrition-based management of patients with cancer. Proc Nutr Soc. 2008 May 1:1-6.
3.
Fouladiun M, Körner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I, Lundholm K.
Daily physical-rest activities in relation to nutritional state, metabolism, and
quality of life in cancer patients with progressive cachexia. Clin Cancer Res.
2007 Nov 1;13(21):6379-85.
4.
Nilsson
AC, Ostman EM, Holst JJ, Björck IM. Including indigestible
carbohydrates in the evening meal of healthy subjects improves glucose
tolerance, lowers inflammatory markers, and increases satiety after a subsequent
standardized breakfast. J Nutr. 2008 Apr;138(4):732-9.
Weickert MO, Pfeiffer AF. Metabolic effects of
dietary fiber consumption and prevention of diabetes. J Nutr. 2008 Mar;138(3):439-42.
5.
Louis-Sylvestre J, Lluch A, Neant F, Blundell JE. Highlighting the
positive impact of increasing feeding frequency on metabolism and weight
management. Forum Nutr. 2003;56:126-8.
6.
Blair
RM, Henley EC, Tabor A. Soy foods have low glycemic and insulin
response indices in normal weight subjects. Nutr J. 2006 Dec 27;5:35.
Losso JN. The biochemical and functional food
properties of the bowman-birk inhibitor. Crit Rev Food Sci Nutr. 2008 Jan;48(1):94-118.
Duranti M. Grain legume proteins and
nutraceutical properties. Fitoterapia. 2006 Feb;77(2):67-82.
Jones LA, Gonzalez R, Pillow PC, Gomez-Garza SA, Foreman CJ, Chilton JA, Linares
A, Yick J, Badrei M, Hajek RA. Dietary fiber,
Hispanics, and breast cancer risk? Ann N Y Acad Sci. 1997 Dec 26;837:524-36.
Hu J, La Vecchia C, Desmeules M, Negri E, Mery L, Group CC.
Meat and fish consumption and cancer in Canada. Nutr Cancer. 2008 May-Jun;60(3):313-24.
Lopez-Garcia E, Schulze MB, Fung TT, Meigs JB, Rifai N, Manson JE, Hu FB.
Major dietary patterns are related to plasma concentrations of markers of
inflammation and endothelial dysfunction. Am J Clin Nutr. 2004 Oct;80(4):1029-35.
7.
Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, Parker S.
The serum insulin and plasma
glucose responses to milk and fruit products in type 2 (non-insulin-dependent)
diabetic patients. Diabetologia. 1986;29(11):784-91.
Lljeberg Elmstagahl H, Bjorck I.
Milk as a supplement to mixed meals may elevate
postprandial insulnemia Eur J
Clin Nutr 2001; 55:994-9
Lawlor DA, Ebrahim S, Timpson N, Davey Smith G.
“Avoiding milk is associated with a reduced risk of insulin resistance
and the metabolic syndrome: findings from the British Women’s Heart and Health
Study.” Diabetic Med. 2005;
22(6):808-11.
8.
Urías-Silvas JE, Cani PD, Delmée E, Neyrinck A, López MG, Delzenne NM.
Physiological effects of dietary fructans extracted from Agave tequilana Gto.
and Dasylirion spp. Br J Nutr. 2008 Feb;99(2):254-61.
Chen JD, Yang ZY, Ma SH, Zhen YC. The effects of
actinidia sinensis planch (kiwi) drink supplementation on athletes training in
hot environments. J Sports Med Phys Fitness. 1990 Jun;30(2):181-4.
Barriocanal LA, Palacios M, Benitez G, Benitez S, Jimenez JT, Jimenez N, Rojas
V.Apparent lack of pharmacological effect of
steviol glycosides used as sweeteners in humans. A pilot study of repeated
exposures in some normotensive and hypotensive individuals and in Type 1 and
Type 2 diabetics.
Regul Toxicol Pharmacol. 2008 Mar 5. [Epub ahead of print]
Myers T. Bakery application of a patented sweetener prepared from fruit juice and rice syrup. Nutritive Sweetener Research Department Bulletin 1993; 15(11). Available at: https://secure.aibonline.org/subscribers/techbulletins/v15iss11.txt. Accessed May 19, 2008.
9.
Chen D,
Milacic V, Chen MS, Wan SB, Lam WH, Huo C, Landis-Piwowar KR, Cui QC, Wali A,
Chan TH, Dou QP. Tea polyphenols, their biological effects and
potential molecular targets. Histol Histopathol. 2008 Apr;23(4):487-96
10.
Environmental Working Group.
Shoppers Guide to Pesticides in Produce.
Available through:
www.foodnews.org.
Accessed May 29, 2008.
11.
Re R,
Bramley PM, Rice-Evans C. Effects of food processing on flavonoids
and lycopene status in a Mediterranean tomato variety. Free Radic Res. 2002 Jul;36(7):803-10.
Fielding JM, Rowley KG, Cooper P, O' Dea K.
Increases in plasma lycopene concentration after consumption of tomatoes cooked
with olive oil. Asia Pac J Clin Nutr. 2005;14(2):131-6.
12.
Larson
E, Nirenberg A. Evidence-based nursing practice to prevent infection
in hospitalized neutropenic patients with cancer. Oncol Nurs Forum. 2004 Jul 13;31(4):717-25.
13.
Fimognari C, Hrelia P. Sulforaphane as a promising molecule for
fighting cancer. Mutat Res. 2007 May-Jun;635(2-3):90-104.
14.
Moriarty
RM, Naithani R, Surve B. Organosulfur compounds in cancer
chemoprevention.
Mini Rev Med Chem. 2007 Aug;7(8):827-38.
15.
Seren S, Lieberman R, Bayraktar UD, Heath E, Sahin K, Andic
F, Kucuk O. Lycopene
in cancer prevention and treatment. Am J Ther. 2008 Jan-Feb;15(1):66-81.
16.
Divisi
D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Diet and cancer.
Acta Biomed. 2006 Aug;77(2):118-23.
17.
Colditz
GA, Branch LG, Lipnick RJ, Willett WC, Rosner B, Posner BM, Hennekens CH.
Increased green and yellow vegetable intake and lowered cancer deaths in an
elderly population. Am J Clin Nutr. 1985 Jan;41(1):32-6.
18.
Robbins J. Diet for a New America.
H.J. Kramer, Tiburon CA. 1998. p. 181.
19.
Shurtleff W, Akiko A. Green
vegetable soybeans, edamame, and vegetable-type soybeans – bibliography and
sourcebook, 1275AD to 2001. 2001.
Soyinfo Center. Available at:
http://soyinfocenter.com/pdf/89/GVS-2001.pdf.
Accessed May 29, 2008.
20.
Ganiats TG, Norcross WA, Halverson AL, Burford PA, Palinkas
LA. Does Beano prevent gas? A
double-blind crossover study of oral alpha-galactosidase to treat dietary
oligosaccharide intolerance.
J Fam
Pract. 1994 Nov;39(5):441-5.
21.
U.S. Dept. of Health and Human Services.
Mercury levels in commercial seafood and fish.
2006. Available at:
http://www.cfsan.fda.gov/~frf/sea-mehg.html.
Accessed May 29, 2008.
22.
Mangels R. Calcium in the vegan diet. Table 1. Available at:
http://www.vrg.org/nutrition/calcium.htm#table1.
Accessed May 19, 2008.
Anon. Calcium content of selected
foods. Available at:
http://www.ucsfhealth.org/adult/edu/calciumContent/index.html
Anderson J. Got milk?
Nondairy sources of calcium. Available at:
http://www.ext.colostate.edu/PUBS/columnha/ha0206.html.
Accessed May 8, 2008.
Anon. Calcium-rich foods.
Available at:
http://www.citracal.com/Calcium/Calcium-Rich-Foods.aspx.
Accessed May 8, 2008.
23.
Environmental Working Group.
Shoppers Guide to Pesticides in Produce.
Available through:
www.foodnews.org.
Accessed May 29, 2008.
24.Envionmental
Working Group. Shoppers Guide.
Available at:
http://www.foodnews.org.
Accessed May 19 2008.
25.
Envirronmental Working Group.
Shoppers Guide. Available at:
http://www.foodnews.org.
Accessed May 19 2008.
26.
http://www.wikipedia.com/inulin.
27.
Monroe
KR, Murphy SP, Kolonel LN, Pike MC. Prospective study of grapefruit
intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort
Study. Br J Cancer. 2007 Aug 6;97(3):440-5.
Fingerová H, Oborná I, Petrová P, Budíková M, Jezdínský J.
[Does grapefruit juice increase the bioavailability of orally administered sex
steroids?] Ceska Gynekol. 2003 Mar;68(2):117-21.
28.
Natural Resources Defense Council.
Bottled water. Pure drink or pure
hype? Available at:
http://www.nrdc.org/water/drinking/bw/exesum.asp.
Accessed May 19, 2008.
29.
vom Saal
FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F,
Guillette LJ Jr, Hauser R, Heindel JJ, Ho SM, Hunt PA, Iguchi T, Jobling S,
Kanno J, Keri RA, Knudsen KE, Laufer H, LeBlanc GA, Marcus M, McLachlan JA,
Myers JP, Nadal A, Newbold RR, Olea N, Prins GS, Richter CA, Rubin BS,
Sonnenschein C, Soto AM, Talsness CE, Vandenbergh JG, Vandenberg LN,
Walser-Kuntz DR, Watson CS, Welshons WV, Wetherill Y, Zoeller RT.
Chapel Hill bisphenol A expert panel consensus statement: integration of
mechanisms, effects in animals and potential to impact human health at current
levels of exposure. Reprod Toxicol. 2007 Aug-Sep;24(2):131-8.
National Toxicology Program. Draft
NTP brief on bisphenol-A. 2008.
Available at:
http://cerhr.niehs.nih.gov/chemicals/bisphenol/BPADraftBriefVF_04_14_08.pdf.
Accessed May 19, 2008.
30.
Haber
GB, Heaton KW, Murphy D, Burroughs LF. Depletion and disruption of
dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet.
1977 Oct 1;2(8040):679-82.
31.
Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, Sutherland RL, Levy J,
Sharoni Y. Lycopene inhibition of
IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr.
2006; 45(5):275-82
32.
Rock CL, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Newman VA, Hollenbach
KA, Jones L, Caan BJ, Pierce JP. Plasma carotenoids and recurrence-free survival
in women with a history of breast cancer. J Clin Oncol. 2005;23(27):6631-8
33.
Fan S, Meng Q, Auborn K, Carter T, Rosen EM. BRCA1 and BRCA2 as molecular
targets for phytochemicals indole-3-carbinol and genistein in breast and
prostate cancer cells. Br J Cancer. 2006;94(3):407-26.
34.
Aggarwal
BB, Ichikawa H. Molecular targets and anticancer potential of
indole-3-carbinol and its derivatives. Cell Cycle. 2005 Sep;4(9):1201-15.
35.
Rock CL. Diet and breast cancer: can dietary factors influence survival?
J Mammary Gland Biol Neoplasia. 2003;8(1):119-32
Rock CL, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Newman VA, Hollenbach
KA, Jones L, Caan BJ, Pierce JP. Plasma carotenoids and recurrence-free survival
in women with a history of breast cancer. J Clin Oncol. 2005;23(27):6631-8
36.
Hernandez LG, Forkert PG. Inhibition of vinyl carbamate-induced
mutagenicity and clastogenicity by the garlic constituent diallyl sulfone in F1
(Big Blue x A/J) transgenic mice. Carcinogenesis. 2007 Aug;28(8):1824-30.
37.
Ishikawa
H, Saeki T, Otani T, Suzuki T, Shimozuma K, Nishino H, Fukuda S, Morimoto K.
Aged garlic extract prevents a decline of NK cell number and activity in
patients with advanced cancer. J Nutr. 2006 Mar;136(3
Suppl):816S-820S.
38.
Fukao H,
Yoshida H, Tazawa Y, Hada T. Antithrombotic effects of odorless
garlic powder both in vitro and in vivo. Biosci Biotechnol Biochem. 2007 Jan;71(1):84-90.
39.
Borek C.
Garlic reduces dementia and heart-disease risk. J Nutr. 2006 Mar;136(3
Suppl):810S-812S.
40.
Satoskar RR,
Shah SJ,
Shenoy
SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl
methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther
Toxicol.1986;24:651-4;
Karunagaran D, Rashmi R, Kumar TR.
Induction of apoptosis by curcumin and its implications for cancer therapy. Curr
Cancer Drug Targets. 2005;5(2):117-29.
Singh S, Khar A. Biological effects
of curcumin and its role in cancer chemoprevention and therapy. Anticancer
Agents Med Chem. 2006;6(3):259-70.
Chauhan DP. Chemotherapeutic
potential of curcumin for colorectal cancer.
Curr
Pharm Des. 2002;8(19):1695-706
Du B, Jiang L, Xia Q, Zhong L.
Synergistic inhibitory effects of curcumin
and 5-fluorouracil on the growth of the human colon cancer cell line HT-29.
Chemotherapy 2006;52(1):23-8
HemaIswarya S, Doble M. Potential
synergism of natural products in the treatment of cancer. Phytother Res.
2006;20(4):239-49;
41.
Salvatore S,
Pellegrini N,
Brenna OV,
Del Rio D,
Frasca G,
Brighenti F,
Tumino R. Antioxidant
characterization of some Sicilian edible wild greens.
J Agric
Food Chem. 2005;53(24):9465-71.
Su Q,
Rowley
KG,
Itsiopoulos C,
O'Dea K.
Identification and quantitation of major carotenoids in selected components of
the Mediterranean diet: green leafy vegetables, figs and olive oil.
Eur J
Clin Nutr.
2002;56(11):1149-54.
42.
Falsaperla M,
Morgia G, Tartarone A, Ardito R, Romano G.
Support ellagic acid therapy in
patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy
using vinorelbine and estramustine phosphate. Eur Urol. 2005;47(4):449-54
43.
Aggarwal BB, Shishodia S.
Suppression of the nuclear factor-kappaB activation pathway by spice-derived
phytochemicals: reasoning for seasoning. Ann N Y Acad Sci. 2004;1030:434-41.
44.
Stoner GD, Mukhtar H. Polyphenols as
cancer chemopreventive agents. J Cell Biochem Suppl. 1995;22:169-80.
45.
Available at:
http://www.ars.usda.gov/Services/docs.htm?docid=6231.
Accessed May 19, 2008.
46.
Cremer L,
Herold A,
Avram D,
Szegli G.
A purified green barley extract with modulatory properties upon TNF alpha and
ROS released by human specialised cells isolated from RA patients.
Roum Arch Microbiol Immunol. 1998 Jul-Dec;57(3-4):231-42.
47.
Kodama N, Murata Y, Asakawa A, Inui A, Hayashi M, Sakai N, Nanba H. Maitake
D-Fraction enhances antitumor effects and reduces immunosuppression by
mitomycin-C in tumor-bearing mice. Nutrition. 2005;21(5):624-
Kimura Y. New anticancer agents: in vitro and in vivo evaluation of the
antitumor and antimetastatic actions of various compounds isolated from
medicinal plants. In Vivo.
2005;19(1):37-60
Yuen JW, Gohel MD. Anticancer
effects of Ganoderma lucidum: a review of scientific evidence.
Nutr Cancer. 2005;53(1):11-7.
Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther.
2003;2(4):358-64.
Kodama N, Komuta K, Nanba H. Effect of Maitake (Grifola frondosa) D-Fraction on
the activation of NK cells in cancer patients. J Med Food. 2003;6(4):371-7.
48.
Kidd PM. The use of mushroom glucans
and proteoglycans in cancer treatment.
Altern Med
Rev 2000; 5(1):4-27.
49.
Broekaert IJ, Walker WA. Probiotics
and chronic disease.
J Clin Gastroenterol. 2006 Mar;40(3):270-4.
50.
Doron S, Gorbach SL.
Probiotics: their role in the treatment and
prevention of disease. Expert Rev Anti Infect Ther. 2006 Apr;4(2):261-75
Broekaert IJ, Walker WA. Probiotics
as flourishing benefactors for the human body. Gastroenterol Nurs. 2006
Jan-Feb;29(1):26-34
Chermesh I, Eliakim R. Probiotics
and the gastrointestinal tract: where are we in 2005? World J Gastroenterol.
2006 Feb 14;12(6):853-7
Guarner F. Enteric flora in health
and disease. Digestion. 2006;73 Suppl 1:5-12
Reid G, Bruce AW. Probiotics to
prevent urinary tract infections: the rationale and evidence. World J Urol. 2006
Feb;24(1):28-32
Senok AC, Ismaeel AY, Botta GA.
Probiotics: facts and myths. Clin Microbiol Infect. 2005 Dec;11(12):958-66
Penner R, Fedorak RN, Madsen KL.
Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal
diseases. Curr Opin Pharmacol. 2005 Dec;5(6):596-603.
Lin DC. Probiotics as functional
foods. Nutr Clin Pract. 2003 Dec;18(6):497-506
5[1]
Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the
recurrence of superficial bladder cancer. BLP Study Group. Urol Int.
1992;49:125–129
52.
Das UN.
Gamma-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and
clinical studies. Med Sci Monit. 2007 Jul;13(7):RA119-31.
53.
Oikarinen SI, Pajari AM, Salminen I, Heinonen SM, Adlercreutz H, Mutanen M.
Effects of a flaxseed mixture and plant oils rich in alpha-linolenic acid on the
adenoma formation in multiple intestinal neoplasia (Min) mice. Br J Nutr. 2005
Oct;94(4):510-8.
54.
Kapoor
R, Huang YS. Gamma linolenic acid: an antiinflammatory omega-6 fatty
acid. Curr Pharm Biotechnol. 2006 Dec;7(6):531-4.
Tapiero H, Ba GN, Couvreur P, Tew KD.
Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and
pathologies. Biomed Pharmacother. 2002 Jul;56(5):215-22.
55.
Yamamoto, I. and M. Ishibashi. "The
content of trace elements in seaweeds." Proceedings of the 7th International
Seaweed Symposium. Wiley and Sons, N.Y. 1972;
pp. 511-514
56.
Hirayama, T. Changing patterns of cancer in Japan. in Hiatt, H.H. et al. (ed)
Origins of Cancer in Humans. Cold Spring Harbor, N.Y., 1977, pp. 55-75.
Haroun-Bouhedja F, Lindenmeyer F, Lu H, Soria C, Jozefonvicz J, Boisson-Vidal C.
In vitro effects of fucans on MDA-MB231 tumor cell adhesion and invasion.
Anticancer Res. 2002 ;22(4):2285-92.
Haneji K, Matsuda T, Tomita M, Kawakami H, Ohshiro K, Uchihara JN, Masuda M,
Takasu N, Tanaka Y, Ohta T, Mori N.
Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human
T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell
leukemia cells. Nutr Cancer. 2005;52(2):189-201
Dias PF, Siqueira JM Jr, Vendruscolo LF, de Jesus Neiva T, Gagliardi AR,
Maraschin M, Ribeiro-do-Valle RM. Antiangiogenic and antitumoral properties of a
polysaccharide isolated from the seaweed Sargassum stenophyllum. Cancer
Chemother Pharmacol. 2005;56(4):436-46
Choi EM, Kim AJ, Kim YO, Hwang JK.
Immunomodulating activity of arabinogalactan and fucoidan in vitro. J Med Food.
2005;8(4):446-53
Liu JM, Bignon J, Haroun-Bouhedja F, Bittoun P, Vassy J, Fermandjian S,
Wdzieczak-Bakala J, Boisson-Vidal C.
Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to
fibronectin. Anticancer Res. 2005;25(3B):2129-33;
Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H.
Oversulfation of fucoidan enhances its anti-angiogenic and antitumor
activities. Biochem Pharmacol. 2003;65(2):173-9.
Yamamoto I, Nagumo T, Fujihara M, Takahashi M, Ando Y.
Antitumor effect of seaweeds. II.
Fractionation and partial characterization of the polysaccharide with antitumor
activity from Sargassum fulvellum.
Jpn J Exp Med. 1977;47(3):133-40.
Yamamoto I, Nagumo T, Yagi K, Tominaga H, Aoki M.
Antitumor effect of seaweeds. I. Antitumor
effect of extracts from Sargassum and Laminaria.
Jpn J Exp Med. 1974;44(6):543-6.
Teas, J.
Harbison ML,
Gelman RS. Dietary
seaweed (Laminaria) and mammary carcinogenesis in rats. Cancer Res. 1984;44:
2758-61
Funahashi H, Imai T, Mase T, Sekiya M, Yokoi K, Hayashi H, Shibata A, Hayashi T,
Nishikawa M, Suda N, Hibi Y, Mizuno Y, Tsukamura K, Hayakawa A, Tanuma S.
Seaweed prevents breast cancer? Jpn J Cancer Res. 2001 May;92(5):483-7.
57.
Anonymous. AquaMUNE, a brown
seaweed extract, improves metabolism, immune response, energy and chelates heavy
metals. Posit Health News. 1998 Spring(No 16):18
Maruyama H, Tamauchi H, Hashimoto M, Nakano T.
Antitumor activity and immune response of Mekabu fucoidan extracted from
Sporophyll of Undaria pinnatifida. In Vivo. 2003 May-Jun;17(3):245-9.
58.
Murphy
V, Hughes H, McLoughlin P. Comparative study of chromium biosorption
by red, green and brown seaweed biomass. Chemosphere. 2008 Jan;70(6):1128-34.
59.
Hultdin
J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Plasma folate,
vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int
J Cancer. 2005 Feb 20;113(5):819-24.
Johansson M, Appleby PN, Allen NE, Travis RC, Roddam AW, Egevad L, Jenab M,
Rinaldi S, Kiemeney LA, Bueno-de-Mesquita HB, Vollset SE, Ueland PM, Sánchez MJ,
Quirós JR, González CA, Larrañaga N, Chirlaque MD, Ardanaz E, Sieri S, Palli D,
Vineis P, Tumino R, Linseisen J, Kaaks R, Boeing H, Pischon T, Psaltopoulou T,
Trichopoulou A, Trichopoulos D, Khaw KT, Bingham S, Hallmans G, Riboli E,
Stattin P, Key TJ. Circulating concentrations of
folate and vitamin B12 in relation to prostate cancer risk: results from the
European Prospective Investigation into Cancer and Nutrition study. Cancer
Epidemiol Biomarkers Prev. 2008 Feb;17(2):279-85.
60.
Smith
AD, Kim YI, Refsum H. Is folic acid good for everyone? Am J Clin Nutr.
2008 Mar;87(3):517-33.
61.
Kabat
GC, Rohan TE. Does excess iron play a role in breast carcinogenesis?
An unresolved hypothesis. Cancer Causes Control. 2007 Dec;18(10):1047-53.
62.
Brewer
GJ, Merajver SD. Cancer therapy with tetrathiomolybdate:
antiangiogenesis by lowering body copper--a review. Integr Cancer Ther. 2002
Dec;1(4):327-37.